Резорцин

Quick links to important sections

Резорцин

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Резорцин

Resorcinol is an International Nonproprietary Name (INN) for a topical medication widely used in dermatology for its unique dual properties. Chemically, it is classified as a phenolic compound. It is applied to the skin in various forms, including creams, ointments, lotions, and specialized chemical peels.

Property Description
Active Ingredient Resorcinol
Common Forms Creams, ointments, lotions, or peels
Pharmacological Class Antiseptic and Keratolytic Agent
Primary Focus Conditions involving scaling, roughness, and mild microbial growth
Status Available in both OTC and Prescription concentrations

Function and Therapeutic Class

Resorcinol is primarily defined by its combination of keratolytic and antiseptic actions. The keratolytic effect allows the drug to help the skin’s outer layer (stratum corneum) soften and peel. This action is crucial for resolving conditions marked by rough, scaly, or thickened skin patches. This process of exfoliation facilitates skin renewal.

In addition to its exfoliating role, Resorcinol possesses mild antiseptic properties. This means it helps disinfect the skin surface and inhibits the growth of various surface bacteria and fungi. It serves as an antiseptic agent in topical applications.

Due to this dual functionality, Resorcinol is frequently formulated with other active ingredients, such as sulfur, to create combination products that target complex dermatological issues like acne, seborrheic dermatitis, and eczema. Its clinical recognition for both exfoliating and disinfectant properties makes it a non-antibiotic component in managing skin surface disorders.

Regulatory References

  1. pharmacological studies

What side effects are possible with Резорцин?

The official safety profile for Resorcinol, as documented in government regulatory sources, addresses both localized reactions and rare, serious systemic effects linked to absorption. The adverse reactions are classified across several System-Organ Classes (SOCs) in official labeling.

Adverse Reaction Classifications

Classification Type Examples of Officially Documented Effects
Common Localized Reactions Skin and Subcutaneous Tissue Disorders, including localized irritation, erythema (redness), and scaling/peeling.
Rare/Systemic Effects Blood and Lymphatic System Disorders (e.g., Methaemoglobinaemia, Haemolytic anaemia), Endocrine Disorders (e.g., Hypothyroidism, Myxedema), and Nervous System Disorders (e.g., Tinnitus).

The most serious adverse reactions documented in regulatory sources—Methaemoglobinaemia, Haemolytic anaemia, and Myxedema—are specifically associated with high levels of systemic absorption.

Safety Constraints and Special Populations

Official labeling contains specific constraints related to application. The risk of cumulative systemic toxicity is associated with prolonged or excessive use. Localized skin irritation is more frequently observed during the initial phase of treatment.

Use is officially restricted to small, localized body surface areas. Furthermore, application to broken, raw, or severely abraded skin surfaces is cautioned against, as this significantly increases the risk of serious systemic effects. Regulatory documents also note that Infants and Children have an explicitly increased vulnerability to systemic absorption and toxicity.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Resorcinol, primarily occurring through excessive dermal application over large or damaged skin areas or accidental ingestion, leads to acute systemic intoxication. The official regulatory profile emphasizes the risk of serious systemic effects that necessitate immediate medical intervention.

Documented Overdose Manifestations

Official documents list clinical manifestations of overdose primarily involving the Central Nervous System (CNS) and Hematological System. Documented symptoms include severe headache, dizziness, nausea, vomiting, sweating, muscle weakness, and a decreased body temperature. A key sign of severe intoxication is methemoglobinemia, which manifests as cyanosis (blue discoloration of the skin and lips) due to reduced oxygen-carrying capacity in the blood.

When to Seek Immediate Medical Attention

Regulatory statements require individuals to seek emergency medical attention immediately, or contact a Poison Help line or doctor, if an overdose is suspected or accidental ingestion occurs. Urgent medical help is mandatory upon the appearance of any systemic effects, particularly seizures, trouble breathing, or the blue discoloration of the skin (cyanosis).

Required Emergency Management

Management procedures, as described in official documents, focus on symptomatic and supportive treatment. There is no specific antidote documented in authoritative sources for Resorcinol poisoning. Furthermore, the regulatory profile highlights that infants and children are more susceptible to systemic absorption and are at higher risk for severe effects, specifically methemoglobinemia.

Therapeutic Uses of Резорцин

What Резорцин Treats: Main Uses and Benefits

Resorcinol is commonly used in topical dermatological products and is relevant for managing various skin symptoms. This agent is applied across conditions presenting with localized or episodic manifestations where additional symptomatic support is needed. It is commonly used to help with conditions characterized by periods of heightened symptoms, including acne vulgaris, seborrheic dermatitis, psoriasis, and localized issues like warts, corns, and calluses.

The primary application is for managing the overall symptom load associated with pathological scaling and follicular concerns. It is relevant for easing symptoms related to hardened, rough skin and is relevant for easing visible congestion in pores. Furthermore, its inclusion in topical formulations provides a supportive therapeutic benefit by addressing symptoms related to surface microbial involvement in conditions like dermatitis.

“Resorcinol plays a role in managing symptomatic relief across conditions marked by excessive skin buildup and superficial microbial involvement.”

In clinical scenarios, it is often used when symptoms intensify and supportive relief is needed, contributing to improved comfort during periods of heightened symptoms.


Quick Fact: Relief for Scaling and Congestion

The agent is commonly used to help manage symptoms related to excessive skin thickening (hyperkeratosis) and clogged pores (blackheads and whiteheads), offering symptomatic relief that helps patients cope more steadily with symptom fluctuations.

Eligibility and Restrictions for Use

Resorcinol (Резорцин) is a topical agent used in certain skin preparations, and its eligibility for use is subject to specific regulatory restrictions and precautions, particularly due to its potential for systemic absorption.

Eligibility scope

Populations for whom use is contraindicated:

  • Patients with a known hypersensitivity or allergy to resorcinol or any component of the product.
  • Application to broken, irritated, or wounded skin, as absorption through damaged skin can increase the risk of systemic toxicity (including methemoglobinemia).
  • Use in infants and young children on large areas of the body due to the heightened risk of absorption and potential for methemoglobinemia, a serious blood condition.

Age-related eligibility rules:

  • Pediatric: Generally not recommended for use on large areas or broken skin in infants and children. Use is contraindicated in children under 2 years for certain indications.

Condition-specific eligibility rules:

  • Patients with pre-existing blood disorders or conditions that increase susceptibility to methemoglobinemia should use with extreme caution.

Pregnancy and lactation eligibility status:

  • Pregnancy: Use is generally not recommended due to a lack of adequate, controlled human studies. It should be used only if the potential benefit justifies the potential risk to the fetus, based on professional advice.
  • Lactation: Use during breastfeeding is not recommended due to insufficient data and the potential for the drug to be absorbed through the skin and possibly excreted in breast milk. Consult a healthcare professional before use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The regulatory interaction profile for topical Resorcinol is defined primarily by restrictions related to local effects and the risk of systemic absorption.

Interaction Scope

Classification Interacting Agents / Conditions
Pharmacodynamic Risk (Additive Irritancy) Other topical peeling or keratolytic agents (e.g., salicylic acid, benzoyl peroxide, tretinoin, adapalene).
Physical Incompatibility (Contraindicated) Topical preparations containing mercury (e.g., ammoniated mercury ointment).
Exposure Constraint (Absorption Risk) Application to large body surface areas, broken skin, or open wounds.
Substance Interaction (Local) Alcohol-containing preparations, abrasive soaps, and cosmetics that dry the skin.

Official Interaction Statements

  • Co-administration with other topical keratolytic or peeling agents is restricted due to the documented risk of cumulative irritancy and excessive desquamation.
  • The combination with topical preparations containing mercury is officially restricted because a physical incompatibility may result in a foul odor, irritation, and black staining of the skin.
  • Applying Resorcinol to compromised skin (large areas, wounds) increases the potential for systemic absorption, which raises the risk of resorcinol poisoning and subsequent systemic toxicity, including methemoglobinemia.
  • Specific caution is noted in infants and children, as they have a higher risk of systemic absorption and related toxicity, restricting the use of the product on large skin areas in this population.

Connection to the overall interaction profile

The official regulatory documents define the interaction structure by placing primary restrictions on the simultaneous co-application of other topical agents that share an irritating or peeling function. This focus is on preventing additive local adverse effects. Additionally, the profile includes label warnings against conditions or routes of use that heighten the risk of systemic exposure and subsequent toxic interactions.

Mechanism of Action

How Резорцин (Resorcinol) Works

Resorcinol exerts its effects through three primary peripheral mechanisms localized to the skin's surface. The molecule acts as a protein denaturant, engaging in a direct chemical interaction that precipitates structural and enzymatic proteins found within both microbial cells and epidermal cells. This non-specific disruption of cellular components inhibits the growth and disrupts the vitality of surface microorganisms, resulting in the physiological effect of cellular component inactivation.

Secondly, the drug initiates keratolysis by chemically interfering with the weak hydrogen bonds that maintain the structural integrity and cohesion of the keratin protein matrix in the outermost layer of the skin (stratum corneum). This action promotes the accelerated shedding (exfoliation) of hardened skin cells.

Lastly, Resorcinol engages the melanogenesis pathway by acting as a reversible inhibitor of the enzyme tyrosinase. This interference slows the biochemical conversion of tyrosine necessary for melanin formation, leading to a reduction in local pigment synthesis.

Dosage and Administration Information

Administration of Resorcinol: Usage Guidelines

Resorcinol is an active ingredient in various topical formulations, and its use is guided by instructions for application. The medication is used exclusively for topical (dermal) purposes.


Use Parameter Standard Protocol
Route of Administration Topical application only; strictly for external use.
Application Pre-condition The skin is thoroughly cleansed before the product is applied.
Dosing Frequency Initial use is typically once daily. Frequency may be gradually increased, but does not exceed three to four applications daily.
Dose Reduction Protocol If signs of excessive dryness or peeling occur, the application frequency is reduced (e.g., to once daily or every other day).
Area of Use Restriction A thin layer is applied only to the affected area; application is avoided over large areas of the body or on broken skin.

Population-Specific and Missed-Dose Rules

The usage instructions for Resorcinol include specific constraints for certain groups. The product is used in children aged two years and older, but its application on large surface areas is restricted due to the potential for absorption.

If a scheduled application is missed, standard practice is to apply it as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose is skipped, and the regular dosing schedule is resumed. The protocol also indicates that hands should be washed immediately after application.

Recent Clinical Evidence

Research evidence / Overview of Studies for Resorcinol

The research surrounding Resorcinol focuses on its study in conditions relevant to its recognized properties. Studies have explored how the agent is applied in various dermatological contexts, with the available evidence differing in focus and scope across conditions.


Evidence for Use in Mild-to-Moderate Hidradenitis Suppurativa (HS)

Resorcinol was studied for its use in research examining outcomes related to mild-to-moderate Hidradenitis Suppurativa. The evidence base includes both small-scale Randomized Controlled Trials (RCTs) and prospective observational studies on adult patients.

Research examined short-term symptom changes, with outcomes related to physical discomfort monitored. Studies tracked changes in lesion numbers and assessed patient-reported outcomes like pain intensity and quality of life. The study designs varied, leading to limited insight regarding the consistency of findings. Follow-up durations were often limited to 12 to 24 weeks, meaning long-term effects are not fully established.


Evidence for Topical Use in Acne and Scaling

Resorcinol was studied for its use in research examining outcomes related to acne vulgaris and various scaling conditions. This evidence base relies significantly on regulatory and historical records, along with older clinical trials. Studies explored the agent's role, often when formulated alongside other active ingredients like sulfur.

Findings describe patterns observed in studies, where changes in lesion counts were monitored in populations with acne. For general scaling conditions, research describes observations related to changes in skin texture. A limitation is that many findings were derived from older trials, and comparative data are still emerging for monotherapy versus other treatments.


What Research Gaps and Uncertainties Remain

The evidence base is characterized by heterogeneity and a reliance on data from older research. Key limitations include the fact that much of the available evidence for traditional uses stems from combination products, making it challenging to isolate the exact contribution of Resorcinol itself. High-quality, large-scale trials for monotherapy are generally sparse. The available research highlights what is known—and what is still uncertain—about this widely used agent.

Key Studies & References

  1. Final rule for over-the-counter (OTC) topical acne medications (Resorcinol and Sulfur Combinations) (Referenced via FDA OTC Monograph final status)

Frequently Asked Questions (FAQ)

Common questions about Резорцин (FAQ)


Q: How quickly does Resorcinol start working after application?

Resorcinol is a keratolytic agent, which means it helps the outer layer of the skin to soften and peel. Expected visible effects, such as mild redness and peeling, may begin to appear after a few days of application. Regulatory data does not specify a precise timeline for the full therapeutic effect; outcomes may vary depending on the treated condition.


Q: Is it normal if Resorcinol causes a slight burning or tingling sensation?

Official safety information notes that redness, irritation, and peeling are among the most common local side effects when using Resorcinol. If the irritation is mild, it may be an expected local reaction. However, if irritation becomes severe, persistent, or is accompanied by excessive dryness, it is recommended to discontinue the product and consult a healthcare professional.


Q: Is Resorcinol safe for use on sensitive skin?

Resorcinol can cause localized skin irritation, which may be more noticeable on sensitive skin. Official product precautions advise avoiding the simultaneous use of abrasive soaps and other topical products that may dry or irritate the skin further. Patients with sensitive skin should exercise caution and monitor for increased skin reactions. Guidance on application frequency should come from a healthcare provider.


Q: Are there age restrictions for the use of Resorcinol?

According to official guidelines, Resorcinol is generally approved for use in children aged 2 years and older. Its use on large body surface areas or on broken skin in children is specifically restricted. This is due to the potential for serious systemic effects in younger patients, who have a heightened risk of systemic absorption.


Q: What should I do if Resorcinol accidentally gets into my eyes?

Resorcinol is for external use only and should be kept away from the eyes and other mucous membranes. If the product accidentally enters the eyes, official instructions state they should be flushed thoroughly and immediately with water.


Q: Can Resorcinol be used to treat herpes?

Official regulatory documents indicate that Resorcinol is approved for conditions such as acne, seborrheic dermatitis, and eczema. Approved indications do not typically list viral infections like Herpes Simplex. The focus of the drug is its action as an antiseptic and keratolytic agent on the skin's surface.


Q: What will happen if I apply too much Resorcinol?

Applying more than the recommended amount or using the product over large areas significantly increases the risk of systemic absorption through the skin. This can lead to signs of Resorcinol poisoning, which may include headaches, dizziness, or nausea. If signs of excessive application or systemic effects occur, it is recommended to discontinue use and consult a healthcare professional.


Q: How does Resorcinol affect the thyroid gland?

Official safety profiles document that rare, serious systemic effects associated with high levels of absorption include Endocrine Disorders, such as Hypothyroidism (underactive thyroid) and Myxedema. Regulatory documents indicate that the risk of these systemic effects is specifically associated with excessive, prolonged, or large-area application, which results in high systemic absorption.


Q: How does Resorcinol interact with eczema-prone skin?

Resorcinol is sometimes indicated in the treatment of eczema due to its exfoliating properties. However, official warnings prohibit its application to open wounds, severely irritated, or damaged skin. This includes severe or broken eczema lesions, as damaged skin significantly increases the risk of systemic absorption.


Q: Why is Resorcinol sometimes called Resorcinolum?

Resorcinol is the established International Nonproprietary Name (INN) for the drug. The term 'Resorcinolum' is a chemical name or a former pharmaceutical synonym. The compound is also chemically known as 1,3-Benzenediol.


Q: What exactly is Resorcinol used for in medicine, besides general purpose?

Resorcinol is officially approved for the topical treatment of several skin conditions. These include acne vulgaris, seborrheic dermatitis, eczema, and psoriasis. It is also sometimes used in preparations for conditions like warts, corns, and calluses due to its cell-shedding properties.


Q: What effect should be noticeable when treating with Resorcinol?

The noticeable effects result from the drug's dual action as an antiseptic and a keratolytic agent. Users should observe the softening and eventual removal of rough, scaly, or hardened skin. The antiseptic action also helps inhibit the growth of surface bacteria and fungi.


Q: Why does Resorcinol sometimes cause temporary skin darkening?

Official information indicates that in rare instances, or as a result of excessive application, a blue-black discoloration of the skin, known as ochronosis, has been reported. Additionally, if Resorcinol is applied alongside topical preparations containing mercury, a distinct black staining reaction can occur on the skin.


Q: Is it true that Resorcinol is used in chemical peels?

Yes, Resorcinol is used in various forms, including creams, ointments, lotions, and specialized chemical peels. This usage is consistent with its strong keratolytic (peeling) action on the outermost layer of the skin.


Q: What scientific studies confirm the effectiveness of Resorcinol?

The effectiveness of Resorcinol for its traditional uses, such as treating acne and scaling conditions, is based on historical evidence and is included in regulatory monographs for over-the-counter preparations. The official data supports its long-standing use in dermatology.


Q: How deep does Resorcinol penetrate the skin?

When applied to healthy, unbroken skin, the systemic absorption of Resorcinol is generally low, often less than 1%. This indicates that the drug's primary action is localized to the surface of the skin. However, absorption can significantly increase if the product is applied to large body areas or to damaged skin.


Q: Why do some people use Resorcinol for skin lightening?

Resorcinol's mechanism of action is known to include the reversible inhibition of the enzyme tyrosinase. This enzyme is crucial for the creation of melanin (pigment), and its inhibition can lead to a localized reduction in pigment synthesis.


Q: What is the main difference between Resorcinol and Benzoyl Peroxide?

Both are common non-prescription agents used for skin conditions. Official classification identifies Resorcinol as an antiseptic and keratolytic agent. Benzoyl Peroxide, while also keratolytic, is mainly classified as an antimicrobial agent. Co-administration of the two is often restricted due to the increased risk of cumulative skin irritation.


Q: How does Resorcinol help with seborrhea?

Resorcinol is officially indicated for the treatment of seborrheic dermatitis. It assists in managing this condition primarily through its keratolytic properties, which help to exfoliate and remove the rough, scaly, or hardened skin patches associated with seborrhea.


Q: How do I know when to stop using Resorcinol?

It is important not to use Resorcinol for longer than directed by a healthcare professional. Official guidelines state that if local skin irritation becomes severe, worsens, or does not resolve, use should be discontinued. Furthermore, prolonged or excessive use is cautioned against due to the risk of cumulative systemic toxicity.


Q: Can Resorcinol cause hair color change if it gets on the hair?

Official product labeling for some Resorcinol-containing formulations notes a precaution that the medicine may potentially cause the darkening of light-colored hair if it comes into contact with it.


Q: Does Resorcinol help with insect bites?

In some over-the-counter combination products, Resorcinol is included to provide temporary relief of pain and itching. This application is often cited for minor skin irritations, including those caused by minor burns, cuts, and insect bites.


Q: What ingredients can enhance the effect of Resorcinol?

Resorcinol is frequently formulated alongside other active ingredients to enhance its therapeutic effect. Regulatory documents often highlight the use of sulfur in combination products, where it works synergistically with Resorcinol to address complex conditions like acne and seborrheic dermatitis.

How should Резорцин be stored and disposed of?

How to Store and Dispose of Resorcinol

Resorcinol must be stored according to official regulatory guidelines to maintain its chemical stability. The product requires storage at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). It is essential to keep the medicine from freezing and away from excessive heat.


Storage and Safety Mandates

Condition Requirement
Container Integrity Store in a closed container.
Environmental Protection Must be protected from light and moisture.
Child Safety Keep out of the reach of children.

Disposal Instructions

Unused or expired Resorcinol must be disposed of according to local requirements. To protect the environment, the medicine should not be thrown into household wastewater or flushed down a toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Резорцин found in:

A-Z Index: